Clinical efficacy and mechanism of Ginkgo biloba extract in the treatment of elderly ischemic cerebrovascular disease.

The investigation's aim was to explore the medical usefulness and mechanism of GBE in the management of elderly ischemic cerebrovascular disease (ICVD).120 cases of elderly patients with ICVD admitted to our hospital from August 2022 to August 2023 were chosen as participants for this research and the sufferer were allocated to the conventional (60 cases) and GBE group (60 cases) using the method of randomized number. NIHSS score, Barthel index, hemodynamic indexes, serum inflammatory factor levels, platelet-activating factor (PAF) and clinical efficacy were recorded before (T0) and after treatment(T1),and recorded the adverse reactions of the two groups during the treatment. At T1, NIHSS score, WBLSV, PV, HCT, TNF-α, IL-6 and PAF in the two groups, which were all notably reduced compared to T0 and the Barthel index demonstrated a significant increase compared to its T0 value (P<0.05). At T1, GBE group exhibited notably reductions in NIHSS score, WBLSV, PV, HCT, TNF-α, IL-6 and PAF compared to conventional group, whereas Barthel index and the total effective rate were considerably elevated (P<0.05). Incidence of adverse reactions were similar in both groups (P>0.05). GBE has good therapeutic benefits in managing elderly ICVD, effectively facilitate the recuperation of patients' neurological function, has obvious anti-inflammatory effect, improves patients' cerebral circulation and hemorheology indexes and makes the patients' daily life ability significantly improved, which has a good clinical application value.